# Extension Study of Drisapersen in DMD Subjects

> **NCT02636686** · — · NO_LONGER_AVAILABLE · sponsor: **BioMarin Pharmaceutical**

## Conditions studied

- Duchenne Muscular Dystrophy

## Interventions

- **DRUG:** Drisapersen

## Key facts

- **NCT ID:** NCT02636686
- **Lead sponsor:** BioMarin Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2018-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02636686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02636686, "Extension Study of Drisapersen in DMD Subjects". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02636686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*